Skip to main content

AstraZeneca reports ‘historic’ trial results for Enhertu cancer treatment

The pharmaceutical companies said Enhertu demonstrated meaningful survival improvement in patients with breast cancer compared with physician's choice of chemotherapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.